137 related articles for article (PubMed ID: 32468060)
1. Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma.
Chen L; Wang M; Lin Z; Yao M; Wang W; Cheng S; Li B; Zhang Y; Yin Q
Mol Med Rep; 2020 Aug; 22(2):906-914. PubMed ID: 32468060
[TBL] [Abstract][Full Text] [Related]
2. Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Kuruma H; Beraldi E; Fazli L; Zoubeidi A; Gleave ME
Cancer Res; 2011 Sep; 71(17):5838-49. PubMed ID: 21737488
[TBL] [Abstract][Full Text] [Related]
3. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.
Hu Y; Bobb D; He J; Hill DA; Dome JS
Cancer Biol Ther; 2015; 16(6):949-57. PubMed ID: 25920748
[TBL] [Abstract][Full Text] [Related]
4. A new antisarcoma strategy: multisubtype heat shock protein/peptide immunotherapy combined with PD-L1 immunological checkpoint inhibitors.
Li H; Sui X; Wang Z; Fu H; Wang Z; Yuan M; Liu S; Wang G; Guo Q
Clin Transl Oncol; 2021 Aug; 23(8):1688-1704. PubMed ID: 33792840
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin.
Bagatell R; Beliakoff J; David CL; Marron MT; Whitesell L
Int J Cancer; 2005 Jan; 113(2):179-88. PubMed ID: 15455381
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Microwave Ablation-Induced Tumor Destruction and Animal End Point Survival Can Be Improved by Suppression of Heat Shock Protein 90.
Zhai HY; Zhou QF; Dou JP; Liu FY; Zhu XY; Yu J; Liang P
J Ultrasound Med; 2020 Jun; 39(6):1223-1232. PubMed ID: 31880357
[TBL] [Abstract][Full Text] [Related]
7. Promising abscopal effect of combination therapy with thermal tumour ablation and intratumoural OK-432 injection in the rat osteosarcoma model.
Iwai T; Oebisu N; Hoshi M; Orita K; Yamamoto A; Hamamoto S; Kageyama K; Nakamura H
Sci Rep; 2020 Jun; 10(1):9679. PubMed ID: 32541941
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
[TBL] [Abstract][Full Text] [Related]
9. The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines.
McCleese JK; Bear MD; Fossey SL; Mihalek RM; Foley KP; Ying W; Barsoum J; London CA
Int J Cancer; 2009 Dec; 125(12):2792-801. PubMed ID: 19544563
[TBL] [Abstract][Full Text] [Related]
10. Limb salvage in primary malignant bone tumors by intraoperative microwave heat treatment.
Lu S; Wang J; Hu Y
Chin Med J (Engl); 1996 Jun; 109(6):432-6. PubMed ID: 9206074
[TBL] [Abstract][Full Text] [Related]
11. Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression.
Ory B; Baud'huin M; Verrecchia F; Royer BB; Quillard T; Amiaud J; Battaglia S; Heymann D; Redini F; Lamoureux F
Clin Cancer Res; 2016 May; 22(10):2520-33. PubMed ID: 26712686
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 regulates the tumorigenic function of tyrosine protein kinase in osteosarcoma.
Yao ZP; Zhu H; Shen F; Gong D
Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):380-390. PubMed ID: 34767669
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
14. The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2016 Feb; 51(2):274-82. PubMed ID: 26219406
[TBL] [Abstract][Full Text] [Related]
15. Bone tumors of the extremities or pelvis treated by microwave-induced hyperthermia.
Fan QY; Ma BA; Zhou Y; Zhang MH; Hao XB
Clin Orthop Relat Res; 2003 Jan; (406):165-75. PubMed ID: 12579016
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin hydrochloric increases tumour coagulation and end-point survival in percutaneous microwave ablation of tumours in a VX2 rabbit tumour model.
Song X; Liang M; Zhou W; Ren L; Liu Z; Wang G; Wei Q; Wang S
Int J Hyperthermia; 2016 May; 32(3):265-71. PubMed ID: 26905817
[TBL] [Abstract][Full Text] [Related]
17. Interventional radiology for treatment of bone metastases.
Hayek G; Kastler B
Cancer Radiother; 2020 Aug; 24(5):374-378. PubMed ID: 32527694
[TBL] [Abstract][Full Text] [Related]
18. [Microwave heating and neoadjuvant chemotherapy for malignant bone tumor].
Lu S; Wang J; Hu Y
Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):196-9. PubMed ID: 10374534
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of microwave ablation for local treatment of dogs with distal radial osteosarcoma: A pilot study.
Salyer SA; Wavreille VA; Fenger JM; Jennings RN; Selmic LE
Vet Surg; 2020 Oct; 49(7):1396-1405. PubMed ID: 32697356
[TBL] [Abstract][Full Text] [Related]
20. Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.
Nam S; Kim H; Hong D; Park JB; Kim SJ
Anticancer Res; 2017 Nov; 37(11):6291-6302. PubMed ID: 29061812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
